CUSIP 29772L108COMETONQ4 2025
17 filings · latest Oct 30, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Opaleye Management Inc. | 2.86M | $48.36M |
| 2 | Ecor1 Capital, LLC | 2.03M | $34.34M |
| 3 | Blackrock, Inc. | 1.74M | $29.40M |
| 4 | Vanguard Group Inc | 1.35M | $22.81M |
| 5 | Nantahala Capital Management, LLC | 1.18M | $19.89M |
| 6 | Geode Capital Management, LLC | 565.1K | $9.56M |
| 7 | State Street Corp | 501.9K | $8.49M |
| 8 | Morgan Stanley | 493.9K | $8.35M |
| 9 |
| 4 | Dec 9, 2024 | Ecor1 Capital, LLC | 13G | 5.4% | 1.40M | SEC |
| 5 | Sep 12, 2024 | Opaleye Management Inc. | 13G/A | 10.3% | 2.67M | SEC |
| 6 | Apr 30, 2024 | Harrow, Inc. | 13D/A | — | — | SEC |
| 7 | Feb 9, 2024 | Opaleye Management Inc. | 13G/A | 9.8% | 2.52M | SEC |
| 8 | Jan 20, 2023 | Opaleye Management Inc. | 13G/A | 8.6% | 2.17M | SEC |
| 9 | Jan 28, 2022 | Harrow Health, Inc. | 13D/A | — | — | SEC |
| 10 | Jan 24, 2022 | Opaleye Management Inc. | 13G/A | 9.7% | 2.38M | SEC |
See the full Schedule 13D/13G history for Eton Pharmaceuticals Inc.
Unlock full history| 470.9K |
| $7.96M |
| 10 | Oberweis Asset Management Inc/ | 431.3K | $7.29M |